Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab, bendamustine, and lenalidomide in aggressive B-cell lymphoma
NCT00987493Phase 2Completed
- Sponsor
- Swiss Group for Clinical Cancer Research
- Start
- Sep 2009
- Primary completion
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lenalidomide in B-cell non-Hodgkin lymphoma, sponsored by Swiss Group for Clinical Cancer Research. Started Sep 2009; status: completed.
02
Drugs
lenalidomide
03
Conditions
B-cell non-Hodgkin lymphoma
Beyond the preview
Go deeper on NCT00987493.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00987493.